tert-Butyl ((1-(hydroxymethyl)cyclohexyl)methyl)carbamate, 97%, 250mg

N-(2,4-Dinitrophenyl)-6-aminohexanoic Acid>95.0%(HPLC)(T)1g

Bis(4-nitrophenyl) Phosphate [for Phosphodiesterase Substrate]>98.0%(T)1g

5-Methyl-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one, 95.0%, 250mg

1-Naphthylmethylamine>98.0%(GC)(T)5g

6-Chloro-2-methylpyridin-3-ol, 95.0%, 250mg

Ethyl isoxazole-4-carboxylate, 95.0%, 10g

4,4'-((Perfluoro-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))dibenzonitrile, 98%, 1g

(1R,2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid, 97%, 10g

[2-(3,5-dimethylphenoxy)ethyl]ethylamine hydrochloride, 95.0%, 5g

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 0.10 µm, 1 Piece(s)

3-Bromo-4-chlorobenzenesulfonamide, 1g

(R)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)butanoic acid, 98%, 1g